CGP 42446A

Known as: CGP-42'446, CGP42446A, CGP-42446 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2006
02419942006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The purpose of this study was to evaluate the effect of therapeutic insulin-like growth factorI (IGF-I) administration on the… (More)
Is this relevant?
1998
1998
The effect of the bisphosphonate zoledronate (CAS 118072-93-8, CGP 42446) on trabecular bone in two rat models of osteopenia, i.e… (More)
Is this relevant?
1997
1997
Bisphosphonates are used clinically to inhibit bone resorption but they may also cause renal damage. For the profiling of new… (More)
Is this relevant?
1997
1997
Zoledronate (CGP 42446) is a third generation imidazole ring containing bisphosphonate that has been found in animal studies to… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1997
1997
This study investigated zoledronate (CGP 42'446), a bisphosphonate, as a potential prophylactic and therapeutic agent against… (More)
Is this relevant?
Review
1997
Review
1997
The prolonged administration of bisphosphonates can reduce the frequency of morbid skeletal events in patients with metastatic… (More)
Is this relevant?
Review
1995
Review
1995
Bisphosphonates are analogues of inorganic pyrophosphate, a naturally occurring chemical in bone. In vitro and animal experiments… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
We have investigated the pharmacologic effects of a new bisphosphonate compound, CGP 42'446 [2-(imidazol-1-yl)-1… (More)
Is this relevant?
1994
1994
Bisphosphonates are now widely used in the treatment of bone diseases, particularly where there is uncontrolled bone resorption… (More)
Is this relevant?